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The only tickborne flavivirus in the United King-dom documented to cause disease in vertebrates 
is louping ill virus (LIV), a virus transmitted by the 
deer/sheep tick, Ixodes ricinus (1). This tick species is 
the most abundant and widely distributed tick species 
in the United Kingdom and a known vector of Lyme 
borreliosis. LIV is most commonly detected in sheep, 
cattle, and red grouse and has been reported in Scot-
land, Wales, and England (primarily Cumbria, Devon, 
and North Yorkshire) (1). Humans are incidental hosts 
for LIV, and infection has been reported infrequently; 
≈45 clinical cases have been linked to encephalitis dur-
ing the past 85 years (1,2). However, the short window 
of acute infection leads to uncertainty about whether 
suspected cases resulted from LIV infection or some 
other cause, although serologic analysis to analyze 
recent exposure through induction of IgM-specific re-
sponses, in combination with clinical symptoms, could 
inform a presumptive diagnosis. Human cases are 
mostly linked to occupational exposure, particularly in 
abattoir or farm workers and occasionally in laborato-
ry staff (2). Although the UK Animal and Plant Health 
Agency holds a database of confirmed diagnoses of 
LIV in livestock (3,4), the distribution and regional 
prevalence of LIV has not been fully defined. Records 
of distribution and regional prevalence are based on 
voluntary submissions by farmers and veterinarians 
from symptomatic livestock (1), from which private 
submissions are not integrated. Serologic analysis has 
been complicated; some animals received vaccination 
before its withdrawal.
Tick-borne encephalitis virus (TBEV) is a closely 
related flavivirus that, although known to be less viru-
lent than LIV for sheep (5), causes a neurologic disease 
(tick-borne encephalitis [TBE]) after transmission to 
humans by infected ticks, producing clinical disease 
in an estimated one third of TBEV infections (6). TBE 
typically has a biphasic course starting with a prodro-
mal phase with influenza-like symptoms, followed by 
a symptom-free interval before neurologic disease oc-
curs; neurologic disease ranges from mild meningitis 
to severe encephalitis with or without myelitis and spi-
nal paralysis (7). Three classic subtypes of TBEV are 
recognized: European (TBEV-Eu), Siberian, and Far 
Eastern. Two additional TBEV subtypes have recently 
Tick-Borne Encephalitis Virus,  
United Kingdom
Maya Holding, Stuart D. Dowall, Jolyon M. Medlock, Daniel P. Carter, Steven T. Pullan,  
James Lewis, Richard Vipond, Mara S. Rocchi, Matthew Baylis, Roger Hewson
RESEARCH
During February 2018–January 2019, we conducted 
large-scale surveillance for the presence and preva-
lence of tick-borne encephalitis virus (TBEV) and louping 
ill virus (LIV) in sentinel animals and ticks in the United 
Kingdom. Serum was collected from 1,309 deer culled 
across England and Scotland. Overall, 4% of samples 
were ELISA-positive for the TBEV serocomplex. A focus 
in the Thetford Forest area had the highest proportion 
(47.7%) of seropositive samples. Ticks collected from 
culled deer within seropositive regions were tested for 
viral RNA; 5 of 2,041 ticks tested positive by LIV/TBEV 
real-time reverse transcription PCR, all from within the 
Thetford Forest area. From 1 tick, we identified a full-
length genomic sequence of TBEV. Thus, using deer as 
sentinels revealed a potential TBEV focus in the United 
Kingdom. This detection of TBEV genomic sequence in 
UK ticks has important public health implications, espe-
cially for undiagnosed encephalitis.
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been proposed: Baikalian subtype and the Himala-
yan subtype (8). TBEV-Eu is the prevailing subtype 
in Western Europe where it is primarily transmitted 
by I. ricinus ticks and is maintained within forest and 
meadow biotypes in endemic foci. In the United King-
dom, TBE is considered an imported disease; opportu-
nities for the virus to become established principally 
are limited because the UK climate was not thought to 
support the specific conditions required for enzoonotic 
cycles to be established for TBEV to become endemic 
(9). However, changes in climate have affected the 
emergence, distribution, and abundance of I. ricinus in 
the United Kingdom (10); thus, the risk for tickborne 
disease has increased (11). A recent study provided 
evidence that co-infestation of tick larvae and nymphs 
occurs in small mammals in UK woodland (12). The 
increasing range of TBEV in Western Europe was un-
derscored recently when the Netherlands reported 
its first human case in 2016 (13). Moreover, retrospec-
tive serologic screening of deer serum samples and 
molecular analysis of questing ticks found evidence 
of TBEV circulation in the Netherlands as far back as 
2010 and 2015 (13,14). Given the increasing possibility 
that TBEV could be circulating in the United Kingdom, 
Public Health England developed a surveillance pro-
gram focusing on wild animals and ticks.
In TBEV-endemic areas in continental Europe, 
the prevalence of TBEV in questing ticks is low, rare-
ly exceeding 1% even in regions where the incidence 
of human infections is high (15). Therefore, instead 
of screening ticks directly, we used sentinel animals 
first to identify serologic evidence of TBEV to high-
light sites for focused tick testing by specific TBEV 
detection using real-time reverse transcription PCR 
(rRT-PCR). Deer are proven as reliable sentinels for 
identifying areas where TBEV is present (13,15) be-
cause they have a limited home range, are available 
in large numbers, and are broadly dispersed within 
the surveillance areas. They also show long-lasting 
antibody responses after natural exposure to flavi-
viruses (15,16).
For our study, collectors retrieved blood samples 
from deer culled in England and Scotland during Feb-
ruary 2018–January 2019; when available, they also 
collected tick samples. We tested the blood samples 
for TBEV or LIV antibodies and the ticks for the pres-
ence of viral RNA by rRT-PCR. 
Methods
Sample Collection
We recruited persons involved in routine manage-
ment of deer from across the United Kingdom to 
collect serum and tick samples from any species of 
deer. This program was promoted through organi-
zations involved in deer management. These deer-
stalkers submitted 1,323 serum samples (and tick 
samples where present) from deer culled in England 
and Scotland during February 2018–January 2019. 
The University of Liverpool Ethics Committee (ref: 
VREC596) granted ethics approval for this study on 
February 1, 2018.
Blood samples were collected in serum-separa-
tion vacutainers from the chest cavity during grallo-
ching, and blood-fed ticks were collected from any lo-
cation on the deer carcass. Samples were centrifuged 
at 1,500 relative centrifugal force for 10 min and ali-
quoted. Serum and tick samples were stored at −80°C 
until further processing.
ELISA Testing
We tested serum samples for antibodies to TBEV us-
ing the commercial Immunozym FSME IgG All Spe-
cies ELISA (Progen, https://www.progen.com) ac-
cording to the manufacturer’s instructions. We read 
plates at an optical density ratio of 450 nm. We con-
sidered samples with a reading of >127 Vienna units/
mL to be seropositive.
Hemagglutination Inhibition Testing
We tested serum samples for antibodies to LIV using 
a hemagglutination inhibition (HAI) test (17,18). We 
considered samples with a titer >20 seropositive. A 
small number of samples did not have sufficient se-
rum for HAI testing.
Tick Identification and RNA Extraction
We morphologically identified all ticks collected 
from culled deer within a 15-km radius of any TBEV 
ELISA–seropositive deer (19) to life stage and spe-
cies level. We individually homogenized the ticks 
in 300 μL RLT buffer (QIAGEN, https://www.qia-
gen.com) in MK28-R Precellys homogenizing tubes 
using a Precellys 24 homogenizer (Bertin, https://
www.bertin-instruments.com) at 5,500 rpm for 5 sec, 
followed by a 30-sec break; we repeated this process 
4 times. We then added 300 µL of isopropanol and 
passed the tick homogenate through a QIAshredder 
(QIAGEN). We extracted total RNA using the BioS-
print 96 One-For-All Vet Kit (QIAGEN) and eluted 
it into 100 μL AVE buffer according to the manufac-
turer’s instructions.
rRT-PCR
We tested individual tick samples for LIV/TBEV 
RNA using a sensitive LIV/TBEV assay (20). We 
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amplified RNA in 20 μL rRT-PCR mix containing 
0.8 μL Invitrogen (https://www.thermofisher.com) 
Superscript III/Platinum Taq Mix, 10 μL Invitrogen 
2X reaction mix, 1.6 μL 50 mmol/L MgSO4,, 1 μL of 1 
μmol/L forward primer, 1 μL of 18 μmol/L reverse 
primer, 0.2 μL of 25 μmol/L probe, 5 μL template, 
and 0.4 μL molecular-grade water. 
We also tested all RNA-positive samples using a 
secondary assay designed to detect only LIV (21). We 
amplified RNA in 20 μL rRT-PCR mix containing 0.8 
μL Invitrogen Superscript III/Platinum Taq Mix, 10 
μL Invitrogen 2X reaction mix, 0.8 μL of 10 μmol/L 
forward primer, 1.8 μL of 10 μmol/L reverse primer, 
1.0 μL of 5 μmol/L probe, 5 μL template, and 0.6 μL 
molecular-grade water.
Sequencing and Phylogenetic Analysis
We prepared the tick sample that showed a high level 
of TBEV RNA for metagenomic RNA sequencing (22) 
and assembled the sequencing data using SPAdes ver-
sion 3.1.1 (23). We inferred the evolutionary history 
by using the maximum-likelihood method based on 
the Tamura 3-parameter model (24). We used the tree 
with the highest log likelihood. We automatically ob-
tained initial trees for the heuristic search by applying 
neighbor-joining and BioNJ (25) algorithms to a matrix 
of pairwise distances estimated using the maximum 
composite likelihood approach and then selecting the 
topology with superior log likelihood value. The anal-
ysis involved 10 full-length genomic TBEV nucleotide-
sequences and was performed using Molecular Evo-
lutionary Genetics Analysis version 7.0 software (26).
Results
Deerstalkers submitted a total of 1,323 serum sam-
ples, of which 14 samples were excluded from anal-
ysis because of insufficient location or deer species 
information. Serum samples were obtained from 5 
deer species and a hybrid of 2 species; 61% of samples 
submitted were from male deer. The most frequently 
sampled species were roe deer (Capreolus capreolus) 
(51%), followed by fallow deer (Dama dama) (19%). 
Samples were submitted from across Scotland and 
England, but distribution and density of samples var-
ied by county (Figure 1, panel C). A limited number 
of samples were submitted from across the Midlands 
and parts of Northern England; no samples were sub-
mitted from Wales.
Of serum samples from across the United King-
dom, 4% were positive by ELISA, and 5% by HAI. 
Cohen’s κ indicated substantial agreement (0.61) be-
tween the methods, indicating ELISA results agreed 
closely with HAI test results (Table 1). ELISA yielded 
positive results in all deer species for which it was 
used. These were 27/663 roe, 10/246 fallow, 9/242 
red deer (Cervus elaphus), 6/108 muntjac (Muntiacus 
reevesi), 1/48 sika (Cervus nippon), and 0/2 red/sika 
hybrids. HAI determined the following positives: 
28/662 roe, 15/245 fallow, 18/242 red, 7/106 munt-
jac, 0/45 sika, and 1/2 red/sika hybrid.
Figure 1. Results for deer serum samples and ticks tested for tick-borne encephalitis virus, United Kingdom. A, B) Number of samples 
tested and seroprevalence of samples positive by ELISA (A) and HAI (B). C) Number of ticks tested by county; inset shows magnification of 
testing area with ticks positive by real-time reverse transcription PCR. HAI, hemagglutination inhibition. Source: Ordnance Survey data,  
© Crown copyright and database right 2019; and National Statistics data, © Crown copyright and database right 2019.
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ELISA- and HAI-positive samples were geo-
graphically distributed to specific areas (Figure 1, 
panels A, B); seroprevalence was high in southwest-
ern Norfolk and northwestern Suffolk (Thetford For-
est) in the east of England. Norfolk had the highest 
seroprevalence detected by ELISA (51.4%), followed 
by Hampshire (14.3%), Suffolk (10.7%), and Scottish 
Highlands (8.6%) (Table 2).
Of all ticks submitted from deer carcasses, 2,041 
collected from 339 deer were from within 15 km of 
an ELISA-positive result. All ticks were identified as 
I. ricinus; 1,450 were adult females, 585 adult males, 
and 6 nymphs. Tick availability for testing by area of 
seropositive foci varied (Figure 1, panel C); most ticks 
tested were collected from Argyll and Bute, and an 
average of 6 ticks were tested per deer. Five (4 adult 
males, 1 adult female) of the 2,041 ticks tested positive 
by the LIV/TBEV rRT-PCR (20) and were all within 
the Norfolk/Suffolk focus (Figure 1, panel C). No LIV 
RNA was detected in these 5 ticks when they were 
tested by rRT-PCR designed to detect only LIV (21). 
The 192 ticks tested from within the Norfolk/Suffolk 
focus resulted in a prevalence of 2.6% in this area.
One tick (male) showed high levels of TBEV RNA 
(cycle threshold 15.4). Sequencing revealed a full-
length TBEV genome designated TBEV-UK (Gen-
Bank accession no. MN128700). Phylogenetic analysis 
illustrates this as a TBEV-Eu subtype; it is most close-
ly related to the Norwegian Mandal strain of TBEV 
isolated from ticks in 2009 (Figure 2), sharing a 99% 
sequence identity.
Discussion
The detection of TBEV in the United Kingdom is im-
portant because TBEV can infect humans, causing fe-
brile illness and neurologic complications including 
encephalitis. This evidence is contrary to earlier pre-
dictions based on climate change (9) that did not fore-
cast a spread of TBEV to the United Kingdom. How-
ever, in addition to climate change, the spread of the 
tick vector, TBEV, and associated viruses into new re-
gions can be influenced by a variety of other factors, 
such as transportation of animals and alterations in 
land management (27).
Serologic evidence suggests a high prevalence 
(47.7%) of exposure of deer to flaviviruses, such as 
TBEV and LIV, in the Norfolk/Suffolk (Thetford 
Forest) focal area. This seroprevalence is within the 
upper levels detected in TBEV risk areas of Europe, 
where seroprevalence studies in deer rarely exceed 
50% (15,16,28,29). In addition, the detected prevalence 
of flavivirus RNA in ticks collected from deer of 2.6% 
within the Thetford Forest area falls within the range 
of findings from other studies in mainland Europe 
that tested blood-fed ticks (15). The deer were culled 
within a large forest habitat, which aligns closer with 
ecology required for TBEV, rather than LIV, mainte-
nance (7). Based on these findings, and the evidence 
that all rRT-PCR–positive results were for TBEV and 
not LIV, we propose that TBEV is established and 
is being maintained through enzootic cycles within 
the Thetford Forest area, rather than resulting from 
multiple importation events, which is in line with 
 
Table 1. Variation between ELISA for tick-borne encephalitis 
virus and HAI for louping ill virus, United Kingdom* 
ELISA result 
HAI result 
Not tested Total Positive Negative† 
Positive 38 14 1 53 
Negative‡ 31 1,219 6 1,255 
Total 69 1,233 7 1,309 
*HAI, hemagglutination inhibition. 
†HAI negative, borderline, unknown. 
‡ELISA negative/borderline. 
 
 
Table 2. ELISA- and HAI-positive results for tick-borne encephalitis virus from counties from which serum samples were submitted, 
United Kingdom* 
County and country 
ELISA 
 
HAI 
No. positive/no. tested  % Positive (95% CI)† No. positive/no. tested % Positive (95% CI)† 
Norfolk, England 18/35  51.43 (35.57–67.01)  16/35  45.71 (30.46–61.82) 
Hampshire, England 15/105  14.29 (8.74–22.35)  14/104  13.46 (8.07–21.46) 
Suffolk, England 3/28  10.71 (2.90–28.01)  2/28  7.14 (0.90–23.73) 
Highland, Scotland 7/81  8.64 (3.99–17.04)  8/81  9.88 (4.86–18.53) 
Perth and Kinross, Scotland 2/33  6.06 (0.68–20.60)  10/33  30.30 (17.25–47.46) 
Dorset, England 2/72  2.78 (0.19–10.15)  0/70  0.00 (0.00–6.23) 
Cumbria, England 2/95  2.11 (0.12–7.81)  4/95  4.21 (1.31–10.67) 
Argyll and Bute, Scotland 3/158  1.90 (0.40–5.69)  5/158  3.16 (1.16–7.39) 
Wiltshire, England 1/56  1.79 (0.00–10.34)  5/55  9.09 (3.53–19.99) 
Stirling, Scotland 0/2  0.00 (0.00–70.98)  1/2  50.00 (9.45–90.55) 
Somerset, England 0/13  0.00 (0.00–26.59)  1/13  7.69 (0.00–35.42) 
Moray, Scotland 0/19 0.00 (0.00–19.79)  1/19  5.26 (0.00–26.48) 
Gloucestershire, England 0/24  0.00 (0.0016.31)  1/24  4.17 (0.00–21.87) 
Aberdeenshire, Scotland 0/32  0.00 (0.00–12.73)  1/32  3.13 (0.00–17.11) 
*HAI, hemagglutination inhibition. 
†95% CIs computed by Agresti Coull method. 
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findings in many endemic focal areas of TBEV (30). 
The hypothesis that TBEV infection might be main-
tained in Thetford Forest is supported by previous 
work in the United Kingdom that provided evidence 
of co-feeding between ticks from different life stages 
on small mammals in a southern English woodland, 
which is a crucial factor for the maintenance of TBEV 
(9,12). In addition, our positive serology data sup-
port the concept that the virus is circulating nonvi-
remically in local wildlife and by cycling among the 
co-feeding nymphs, larvae, and adult ticks, through 
nonviremic transmission. Good evidence shows that 
TBEV is maintained in other parts of Europe through 
nonviremic transmission (31).
In other study areas, we detected serologic evi-
dence of flavivirus exposure but not viral RNA in 
ticks. The close homology between LIV and TBEV 
presents challenges when serologic methods are used 
alone because the tests cannot distinguish between 
them. Thus, based on such data, confirming which 
virus is responsible for the seroreactivity in the areas 
where LIV has previously been reported is not pos-
sible. Previous reports of LIV prevalence are limited; 
just one study showed up to 15.3% of ticks positive 
for LIV (32). However, other researchers have not 
confirmed these data, and our results indicate a much 
lower prevalence. Nevertheless, we did not find any 
published clinical reports of LIV in Hampshire live-
stock despite our detected seroprevalence of 14.3% 
by ELISA (1,3,4). Although additional tick and small 
mammal ecology studies are needed to build on sero-
logic data, evidence shows the maintenance of TBEV 
in the identified focal endemic area.
The genomic sequence of TBEV-UK shows close 
identity to a TBEV-Eu virus isolated in 2009 from 
questing ticks collected in Norway. This similarity 
suggests that TBEV-UK might have been brought 
to the United Kingdom on migratory birds, such as 
blackbirds (Turdus merula) and redwings (Turdus ilia-
cus) (33), which are known to transport ticks over wide 
distances (34–37). The United Kingdom experiences 
a large influx of migratory birds each autumn from 
several TBEV-endemic countries in northern Europe, 
including Norway. During this migration, birds first 
arrive on the east coast of the United Kingdom, and it 
is feasible that TBEV-UK could have originated from 
a tick imported by an autumn migratory bird. We are 
collecting tick samples from migratory birds to as-
sess the proportion of tick-infested birds arriving in 
the United Kingdom and testing these imported ticks 
for TBEV (among other potential pathogens). In addi-
tion, because of lower viral RNA levels, we are look-
ing into primer-amplification sequencing approaches 
to further decipher the virus responsible for the rRT-
PCR–positive samples detected from Thetford Forest.
For zoonotic infections, detection of a pathogen 
in the animal reservoir/host, vector, or both often 
precedes the emergence of human infection (38). Such 
was the case in the Netherlands, where deer serum 
samples, collected 6 years before the first cases in hu-
mans (13), demonstrated serologic evidence of TBEV 
infection (14). Similarly, in Spain, Crimean-Congo 
hemorrhagic fever virus was first reported in ticks in 
2010 (39), before autochthonous infections in humans 
was identified in 2017 (40). Within the focal TBEV-
endemic areas we identified in this study, seroepide-
miologic studies should be undertaken, particularly 
in risk groups that include patients presenting to gen-
eral practitioners and hospitals with central nervous 
system symptoms. 
Although UK-TBEV has not been linked to hu-
man disease, it nevertheless shows close homology 
Figure 2. Phylogenetic relationship between TBEV-UK from a 
tick in the United Kingdom and contemporary strains of TBEV. 
The tree was constructed with a maximum-likelihood analysis 
using full-length complete TBEV genomes and is rooted with the 
tickborne Powassan virus. GenBank accession numbers of each 
sequence are provided in brackets. TBEV, tick-borne encephalitis 
virus; TBEV-Eu, TBEV-European; TBEV-FE, TBEV-Far Eastern; 
TBEV-S, TBEV-Siberian; TBEV-UK, TBEV-United Kingdom.
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to pathogenic isolates of TBEV and should be con-
sidered to be a potential public health risk. Thus, 
clinicians in the United Kingdom should consider 
the European Union case definition of TBE (41) and 
include TBE in the differential diagnosis of patients 
with symptoms of meningoencephalitis, especially 
if they have been exposed to a tick bite, even if they 
have not traveled recently to a known TBE-endemic 
country. The European Union case definition speci-
fies clinical criteria as any person presenting with 
inflammation of the central nervous system. In addi-
tion to meeting clinical criteria, laboratory case con-
firmation requires >1 of the following 5 criteria to be 
satisfied: 1) detection of TBEV nucleic acid, 2) viral 
isolation from clinical specimens, 3) TBEV-specific 
IgM and IgG in blood, 4) TBEV-specific IgM in ce-
rebrospinal fluid, and 5) seroconversion or 4-fold 
increase of TBEV-specific antibodies in paired se-
rum samples (41).
Although no autochthonous cases of clinical hu-
man disease have been diagnosed in the United King-
dom, up to 60% of encephalitis cases reach no diag-
nosis (42). Therefore, our results indicate that TBEV 
should be considered as a potential cause in encepha-
litis patients, and the wide distribution of the natu-
ral vector in the United Kingdom indicates a need 
for close monitoring and a potential for geographic 
spread and expanding risk areas.
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